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Abstract
Background: Foot complaints have been shown to be common in systemic lupus erythematosus (SLE) and
heterogeneous in nature. We aimed to categorize self-reported foot complaints in people with SLE and foot
symptoms.
Methods: A self-administered validated questionnaire was posted to 406 people with SLE attending adult
rheumatology clinics across three health boards in Auckland, New Zealand. In addition to foot pain, vascular
complaints, dermatological lesions and neurological symptoms were included in the analysis. Pairwise correlations
among the variables were undertaken followed by factor analysis to identify and categorise associations between
reported foot complaints.
Results: From the questionnaires returned, 93 full datasets were analysed. Participants’ were predominantly female
(n = 87, 93.7%), with mean (SD) age of 50.4 (14.3) years and a mean (SD) disease duration of 13.1 (11) years. Three
categories of foot complaint were determined: ‘foot pain’, ‘skin disorders’ and ‘vascular insufficiency’. These three
groups provided the best fit (0.91) to describe the wide range of foot complaints reported by those with SLE. Factor
analysis for foot pain demonstrated a high positive loading for the inter-correlation of foot pain in past month (0.83),
foot pain today (0.71), intermittent claudication (0.71), numbness (0.62), loss of balance (0.81), swelling (0.59), foot joint
pain (0.77), arch pain (0.68) and tendon pain (0.77). Skin disorders demonstrated a very high positive loading for 3
factors skin rash (0.82), blistering skin rash (0.95) and foot ulceration (0.88). In vascular insufficiency a high positive
loading for cold feet (0.83), chilblains (0.76) and Raynaud’s phenomenon (0.70).
Conclusions: This work suggests people with SLE report three independent categories of foot complaints; foot pain,
skin disorders or vascular insufficiency.
Keywords: Systemic lupus Erythematosus, Foot complaints, Foot pain, Vascular, Dermal
Background
Systemic lupus erythematosus (SLE) is a systemic auto-
immune disease in which multi-organ involvement can
be common leading to a debilitating disease with serious
comorbidity [1, 2]. Recent studies have reported that
foot involvement in SLE is heterogeneous and has a sub-
stantial negative impact on participants’ mobility, quality
of life and well-being [3, 4]. In people with SLE, high
levels of clinical and ultrasound-detected inflammatory
joint abnormalities have been reported in the foot [5–7].
However, there is limited evidence regarding both the
nature and extent of foot disease in SLE [8]. We aimed
to categorize self-reported foot complaints in people
with SLE and foot symptoms.
Methods
Previously described [3], we developed, tested and vali-
dated a self-reported questionnaire to identify, from a
patient’s perspective, the nature and extent of complaints
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affecting the feet in SLE. We designed a questionnaire
from first principles with the aim of identifying, from a
patient’s perspective, the nature and extent of complaints
affecting the feet. This foot-specific questionnaire was
devised by initially combining aspects from a series of
different, yet complementary sources including illness
narratives, disease indices specific to SLE, foot specific
outcome measures and interviews with consultant rheu-
matologists, leading to a 31-item first draft. Patients with
SLE were part of an advisory group and completed the
draft questionnaire and commented on its design, con-
tent and scoring as part of a cognitive debriefing process.
Following this process the questionnaire was re-drafted
and a longer 40-item version produced. The question-
naire was designed to elicit ordinal, nominal, categorical
and interval data, as well the affording patients the op-
portunity to provide more detailed responses in open
questions. A pilot study of the questionnaire was carried
out with patients attending outpatient rheumatology ap-
pointments at two teaching hospitals in the UK over a
3-month period receiving a copy of the questionnairem
prior to cross cultural changes to make the instrument
suited to a New Zealand population [3]. As this might
inadvertently only sample those with the more severe
forms of the disease: members of a patient support
group also agreed to receive copies of the questionnaire.
Following analysis of these results, no items in the ques-
tionnaire were considered to be redundant nor were
additional items added. However, minor adjustments to
the wording of some questions and some response op-
tions were undertaken. Internal consistency was good
(α > 0.75). The questionnaire (Additional file 1)
enquired about demographic data and clinical charac-
teristics of SLE including medication use, together with
foot pain and its anatomical location, extra-articular
features complaints affecting the feet and the effect of
foot complaints on participants’ well-being and activ-
ities of daily living, together with any foot-specific
treatment received.
The questionnaire was posted to 406 people with SLE
attending adult rheumatology clinics across three district
health boards in Auckland, New Zealand. Eligible partic-
ipants were >18 years old, had a diagnosis of SLE con-
firmed by a consultant rheumatologist and had attended
an adult rheumatology clinic for management of SLE in
the previous 2 years. Patients with juvenile SLE and
other concomitant inflammatory arthropathies were ex-
cluded. From a total of 406 questionnaires, 131 (32%)
Fig. 1 Illustration of the strength of pair-wise correlations between variables. This figure illustrates the strength of correlations between variables
using a pair-wise correlation matrix. Each of the reported variables is in a circle and a blue line indicates positive correlation between variables,
whereas a red line indicates negative correlation. Furthermore the thickness of each line indicates the level strong relationship between variables,
where a thicker line indicates a stronger relationship between variables
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were returned; 32 did not report foot symptoms and six
provided insufficient data, resulting in data from 93 pa-
tients with foot symptoms who were included in this
analysis.
Data analysis, including descriptive analysis and inferen-
tial statistics, were carried out using R 3.2.2, [9] and was
based on the 13 self-reported foot symptoms in SLE: cold
feet, chilblains, Raynaud’s phenomenon, intermittent clau-
dication, skin rash (legs or feet), blistering skin rash, foot
ulceration, numbness, loss of balance, foot swelling, foot
joint pain, arch pain and tendon pain, each described
using an ordinal scale (always, sometimes, never, or no re-
sponse). Additionally, two dichotomous variables - foot
pain today and foot pain in the last month were included
in the analysis. A heterogeneous correlation matrix [10]
was initially computed to analyse the polychoric correla-
tions between ordinal variables. The large number of
pairwise combinations correlations (105 = 15c2) were
computed. For a straightforward understanding of the
complexity of the correlation structure, we presented all
these pairwise combinations correlations in graphical for-
mat (Fig. 1). To truncate the complexity of the features of
foot symptoms in SLE, standard exploratory factor ana-
lysis [11–13], was used to reduce a large number of foot
symptoms in SLE into a smaller set of variables. Based on
the recommendations of Hair et al. [14], we assumed that
the variables had a practically significant impact on the
factors if the factor loadings were either less than −0.5 or
greater than 0.5. This analysis provided simplified struc-
ture of foot symptoms in SLE and straightforward inter-
pretation of the features of foot symptoms in SLE. Very
simple structure (VSS) [15] was then used to identify the
most appropriate number of constructs that define the
heterogeneous nature of foot complaints reported in SLE.
VSS is type of exploratory factor analysis used to identify
an underlying pattern in a larger set of variables and seeks
to determine the optimal number of interpretable factors
[15].
Results
Participants’ with foot symptoms contributing data to
the current analysis (n = 93) were predominantly female
(n = 87, 94%), with mean (SD) age of 50.4 (14.3) years
and mean (SD) disease duration of 13.1 (11) years The
majority of participants were paid workers (n = 51, 53%)
and of New Zealand European ethnicity (n = 47, 51%).
Table 1 provides clinical and demographic detail for the
93 participants included in this analysis.
Using Very Simple Structure (VSS) [15] we found three
possible independent groups (foot pain, skin disorders and
vascular insufficiency) achieved the best fit of 0.91. Figure
2 indicates the underlying structural relationship between
the variables of self-reported foot complaints and the cor-
relation between these three independent factors and the
observed variables. Therefore the three possible independ-
ent groups of foot pain, skin disorders and vascular insuf-
ficiency were sufficient to describe the heterogeneous
variation in foot symptoms reported.
Factor analysis for the foot pain category demonstrated
a high positive loading for the inter-correlation of foot
pain in past month (0.83), foot pain today (0.71), inter-
mittent claudication (0.71), numbness (0.62), loss of
balance (0.81), swelling (0.59), foot joint pain (0.77), arch
pain (0.68) and tendon pain (0.77). All the other vari-
ables were only weakly associated with foot pain. Simi-
larly, skin disorders demonstrated very high positive
loadings for three factors, namely skin rash (0.82),
blistering skin rash (0.95) and foot ulceration (0.88). In
vascular insufficiency a high positive loading was noted
Table 1 Demographic and clinical characteristics from
participants included in the analysis (n = 93)
Characteristic Value
Female sex, n (%) 87 (93.7)
Age (years), mean (SD) 50.4 (14.3)
Disease duration (years), mean (SD) 13.1 (11)
BMI (kg/m2), mean (SD) 28.2 (6.6)
Current smoker, n (%) 20 (21)
Employment status, n (%)
Paid work 51 (53)
Not working 21 (23)
Retired 14 (16)
Unpaid work 5 (6)
Sick leave 1 (1)
Full-time education 1 (1)
Ethnicity, n (%)
New Zealand European 47 (51)
Pacific Island 17 (19)
Asian 13 (14)
Māori 8 (9)
Chinese 5 (6)
Afro-carribean 1 (1)
Medication use a
Hydroxychloroquine, n (%) 75 (81)
Azathioprine, n (%) 18 (19)
Methotrexate, n (%) 16 (17)
Mycophenolate, n (%) 4 (4)
Cyclophosphamide, n (%) 2 (2)
Oral glucocorticoid use, n (%) 43 (46)
Non-steroidal anti-inflammatory drug use, n(%) 26 (28)
Rituximab use, n (%) 5 (6)
aFigures may not add to 100% where some participants took more than
one medication
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for cold feet (0.83), chilblains (0.76) and Raynaud’s
phenomenon (0.70) (Table 2).
Discussion
SLE is a condition with heterogeneous symptoms and
this heterogeneity appears to extend to the foot and
lower limb, with a wide range of complaints reported by
patients [3]. Our findings suggest that foot complaints
reported by those with SLE potentially fall into three
independent categories (foot pain, skin disorders and
vascular insufficiency). These findings may further help
define the clinical history of SLE in the feet.
The foot pain category comprised a wide range of con-
ditions, including foot joint pain, soft tissue pain and
features of neuropathy and vascular insufficiency. Previ-
ous work suggests musculoskeletal pain in SLE has a
prevalence of up to 95% [16]. Additionally, imaging stud-
ies have demonstrated a high prevalence of synovitis in
the feet [5, 7]. Swelling of the feet was more strongly
correlated with tendon pain than foot or arch pain. SLE
does not always present with the florid synovitis seen in
some inflammatory arthropathies [17] and in our dataset
soft tissue synovitis may explain the finding of painful
swelling, but equally may not fully explain foot pain in
SLE. Neurological complaints (numbness and balance is-
sues) also correlated strongly with other aspects of foot
pain. Neurological deficit is not uncommon in SLE [18]
with sensorimotor polyneuropathy and axonal degener-
ation affecting the lower limbs [19, 20]. Abnormal nerve
conduction studies are reported in up to 56% of those
with SLE [19] with clinical signs of neuropathy recorded
in up to 50% [21]. Painful neuropathy affecting the foot
is well recognised as a long-term complication of
diabetes [22], but less frequently associated with inflam-
matory arthritis. While respondents may be reporting
such symptoms; it is also possible that symptoms of
neurological abnormality such as small fibre neuropathy
leads to altered gait parameters. These may have a
Fig. 2 Illustration of factor analysis of foot symptoms. This figure illustrates the strength of the relationship between the different groups of
variables following exploratory factor analysis
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further negative impact on range of musculoskeletal foot
impairments seen in SLE. Intermittent claudication was
strongly associated with other items in the ‘foot pain’
category and it could be argued intermittent claudication
pain might be more properly categorised as ‘vascular
insufficiency’. However, it can be difficult for patients
differentiate between pain of a vascular origin and that
emanating from synovitis or myositis without access to
sophisticated assessment methods.
Vascular disease is a common finding in SLE [23]
and peripheral vascular disease in SLE is not always
associated with the traditional risk factors [24], which
further complicates categorisation. An abnormally low
(<0.9) ankle:brachial pressure index has been reported
in between 15 and 21% of those with SLE [25, 26],
with between 22 and 30% reporting vasospastic com-
plaints such as Reynaud’s [27, 28]. Our findings sup-
port that vascular insufficiency formed a distinct
group with high levels of agreement (all >0.7) be-
tween factors.
Cutaneous lesions are common in SLE and the sec-
ond most frequent finding after musculoskeletal symp-
toms [29]. Muco-cutaneous lesions comprise four items
in current SLE classification criteria [30]. While there
has been a paucity of data relating to the prevalence of
skin lesions in the foot/lower limb: Rome and col-
leagues recently reported skin and nail pathologies to
be present in approximately half of their sample [31].
Therefore the emergence of a distinct ‘skin disorders’
group was not entirely unexpected. Foot ulceration
Table 2 Factor loadings for each variable
NB Figures highlighted in yellow were those included in each of the final cateogires of foot complaint
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however, while not common (reported by up to 15% of
our respondents) was similar to previous prevalence re-
ported in those with rheumatoid arthritis [32]. The very
strong correlation (all >0.82) between foot ulceration, blis-
ters and skin rash indicates a need for vigilance by all clini-
cians managing those with SLE, especially in the light of
the increasing use of immunosuppressive/biologic therapy.
The relationships between heterogeneous foot com-
plaints reported by those in our study further supports
the previously identified need [33], for a targeted multi-
disciplinary (MDT) approach to the care of many pa-
tients SLE. In a recent systematic review of MDT care in
rheumatology [34], only one paper reviewed included
patients with SLE, suggesting people with SLE may be a
relatively-neglected group in the literature addressing
MDT care, which may unfortunately also reflect a limita-
tion on the part of the specialists who often care for this
group of patients to fully utilise an MDT approach [35].
Furthermore, the indices of disease activity [36, 37] fre-
quently used to assess disease ‘activity’ both in clinical
practice and in trials of novel therapeutics, while correl-
ating well with each other [38], do not specifically
include foot complaints, yet foot complaints appear
common in SLE [3, 4]. The independent nature of these
categories may assist clinicians in targeting their history
taking and examination of foot complaints in a complex
disorder such as SLE. Novel ways of helping clinicians
identify and categorise foot complaints could help en-
gender a wider team approach and more precisely target
therapy, both of which would benefit patients.
Our approach is subject to particular limitations. The
response rate was relatively low, but nevertheless, repre-
sented a meaningful number of those with SLE. Our
work was based on self-reported symptoms and self-
report questionnaires are limited due to recall bias.
However, high levels of agreement between self-reported
foot complaints and clinical examination have been re-
ported in rheumatoid arthritis [39]. Moreover, the litera-
ture frequently highlights differences between patient
perception and impact of symptoms and clinical assess-
ment/categorisation [40–42]. That said, while establish-
ing a correlation between any two variables, this is not
sufficient to establish a causal relationship. In particular
the ‘foot pain’ category appears reflects a number of dif-
ferent pathologies including arthritis, aspects of vascular
insufficiency and neuropathy; the latter two often pre-
senting as foot/lower limb pain. Nevertheless this work
is one of the first to consider categorisation of foot com-
plaints in SLE. Given the complex and heterogeneous
nature of an autoimmune disease such as SLE, the clin-
ical presentations are typically diverse [2] and previous
work suggests this is equally true of foot complaints seen
in SLE [3, 4, 7]. Further clinical validation of our pro-
posed models using objective clinical assessment would
be warranted. Equally, refinements of our proposed
model in larger SLE populations would further enhance
the validity and transferability of our findings.
Conclusion
This work suggests three independent categories of foot
complaints are reported by those with SLE.
Additional file
Additional file 1: Survey of foot complaints among people with
systemic lupus erythematosus. (DOC 698 kb)
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